Halozyme Therapeutics | HALO - Market Capitalization


Halozyme Therapeutics reported $10.91B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 209.65B 14.21B Aug/2026
Baxter International USD 11.01B 2.34B Jun/2026
Cara Therapeutics USD 110M 80M Aug/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
DBV Technologies USD 1.23B 327M Mar/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
MannKind USD 1.11B 207M Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Pfizer USD 143.89B 5.44B Aug/2026
United Therapeutics USD 24.42B 1.42B Aug/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024